Latest updates
- Insights Exonate at Biotrinity 2022
- Company news Exonate at Biotrinity 2021
- Insights Exonate announces involvement in exciting STEM outreach project.
- In the press Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
- Company news Exonate receives regulatory approval to start Phase I Clinical Trials in Australia
- Company news Exonate completes Wellcome Trust Seeding Drug Discovery Award programme
- In the press A day in the life of a Senior Scientist
- In the press Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
- Insights Exonate at RANZCO – 8-12th November 2019, International Convention Centre Sydney (ICC)
- Company news Exonate at AusBiotech – 30th October – 1st November 2019, Melbourne Convention Center
- Company news Exonate at American Academy of Opthamology 12-15th October – San Francisco
- In the press Watch Exonate’s Dr. Catherine Beech OBE accept Top 21 #OnetoWatch award from Cofinitve